Dr. Brett Michael Milford, DO

Dr. Milford practices at Intercoastal Medical Group Inc in Sarasota, Florida.

Dr. Milford's NPI, 1306191341, was assigned on July 16, 2012. Dr. Milford graduated from Chicago College of Osteopathic Medicine at Midwestern University in 2012. Dr. Milford holds Florida license OS15282.

Dr. Milford's primary practice is Intercoastal Medical Group Inc, at 943 S Beneva Rd, Sarasota, FL 34232 in Sarasota County. The practice phone is (941) 955-1108.

Dr. Milford's primary practice is Intercoastal Medical Group Inc in Sarasota, Florida. Dr. Milford is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Intercoastal Medical Group. Dmand AI also links Dr. Milford to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Milford practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Milford's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Milford is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Milford is licensed in Florida.

Dmand AI lists angioplasty, cardiac catheterization and pacemaker or defibrillator implantation among the conditions Dr. Milford treats.

CMS data shows 9,609 Medicare services from Dr. Milford across 51 procedure codes in 2024, for 1,663 Medicare patients. Medicare paid $530,674 for them.

CMS counts 1,663 Medicare patients who saw Dr. Milford in 2024. The largest group is 65 to 74, with 704 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Milford's median patient age at 75, with 43% women.

In 2024, Dr. Milford wrote 7,520 Medicare Part D claims for 1,057 patients. 81% of them were for generic drugs. CMS names the drug for 7,260 of them, across 59 drugs with 11 or more claims each, at $1,694,693 in total drug cost. In 2023, CMS named 5,431 claims across 51 drugs.

Dr. Milford accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Milford as offering telehealth. CMS counts 17 procedures of coronary angioplasty and stenting by Dr. Milford, more than 44% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Milford in 2017. Dr. Milford's most frequent co-authors are Mauricio G. Cohen, MD, Jason D. Rauba, MD and Timothy A. Sanborn, MD.

CMS Open Payments shows 182 general payments to Dr. Milford from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. Penumbra, Inc. paid the most, $3,101.

Dr. Milford graduated from Chicago College of Osteopathic Medicine at Midwestern University in 2012. Dr. Milford is a member of AOA.

Dr. Milford is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.